XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statement of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 5,757,487 $ 6,336,075
General and administrative 6,729,817 4,314,164
Change in fair value of related party note 154,832 638,046
Operating loss (12,642,136) (11,288,285)
Other income (expense), net:    
Interest income, net 180,246 172,568
Other income (expense), net (32,370) 330,915
Net loss $ (12,494,260) $ (10,784,802)
Per common share data:    
Basic net loss per common share $ (2.93) $ (2.86)
Diluted net loss per common share $ (2.93) $ (2.86)
Weighted average number of common shares outstanding, basic 4,270,470 3,773,326
Weighted average number of common shares outstanding, diluted 4,270,470 3,773,326
Other comprehensive loss    
Foreign currency translation loss $ (87,340) $ (200,629)
Comprehensive loss $ (12,581,600) $ (10,985,431)